Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Jacob Freda

BA (Hons)

Clinical Trials Assistant

I am a Clinical Trials Assistant for SITU. I help with administration on multiple trials, including MelMarT-II, EndoNET, and SENTINEL.  

EndoNET is a prospective, Phase-III, multicentre randomised controlled trial, evaluating the effectiveness of neo-adjuvant endocrine treatment (hormone therapy prior to surgery) in post-menopausal women with early breast cancer. MelMarT-II is an international Phase III study which seeks to determine whether there is a difference in local recurrence and melanoma survival rates for patients treated with either a 1cm excision margin or 2cm margin for clinical stage II (pT2b-pT4b) primary cutaneous melanoma. 

Before joining SITU, I worked in Human Resources at the Nuffield Department of Population Health. I also held a similar role in SITU as a Temporary Trial Co-ordinator, before joining the department on a permanent basis. I completed a BA (Hons) in English at Durham University, so I love a good natter about books or theatre.